Fund Holdings — Matrix Capital Management Company, LP

Total Portfolio Value
$2.15B
Total Bought
$83.76M
Total Sold
$182.21M
Net Transaction
-$98.45M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ALTAIR ENGR INC12,430,00012,430,00001,187,1891,356,23763.04%+169,048
PERIMETER SOLUTIONS INC(PRM)06,554,000+6,554,000083,7603.89%+83,760
ADAPTIVE BIOTECHNOLOGIES COR(ADPT)650,0000-650,0003,3280—-3,328
AURA BIOSCIENCES INC(AURA)6,922,8706,922,870061,68356,9062.65%-4,777
ZENTALIS PHARMACEUTICALS INC(ZNTL)13,959,97313,959,973051,37342,2991.97%-9,074
ADAPTIMMUNE THERAPEUTICS PLC(ADAPY)37,681,5150-37,681,51535,8130—-35,813
GLOBALFOUNDRIES INC(GFS)16,514,95214,264,952-2,250,000664,727612,10928.45%-52,618
PERIMETER SOLUTIONS SA(PRM)6,725,0000-6,725,00090,4510—-90,451
Page 1 of 1
Matrix Capital Management Company, LP — 13F Holdings — Q4 2024 | TickerTrail